Publication:
Clinical Value of Inflammatory and Neurotrophic Biomarkers in Bipolar Disorder: A Systematic Review and Meta-Analysis.

dc.contributor.authorVega-Nuñez, Amanda
dc.contributor.authorGomez-Sanchez-Lafuente, Carlos
dc.contributor.authorMayoral-Cleries, Fermin
dc.contributor.authorBordallo, Antonio
dc.contributor.authorRodriguez-de-Fonseca, Fernando
dc.contributor.authorSuarez, Juan
dc.contributor.authorGuzman-Parra, Jose
dc.contributor.funderRed de Investigación en Atención Primaria de Adicciones (RIAPAd)
dc.contributor.funderInstituto de Salud Carlos III (ISCIII)
dc.contributor.funderMinisterio de Ciencia e Innovación
dc.contributor.funderEuropean Regional Development Funds-European Union (ERDF-EU),
dc.contributor.funderMinisterio de Sanidad, Delegación de Gobierno para el Plan Nacional sobre Drogas
dc.contributor.funderConsejería de Salud y Familia, Junta de Andalucía
dc.date.accessioned2023-05-03T13:48:28Z
dc.date.available2023-05-03T13:48:28Z
dc.date.issued2022-06-09
dc.description.abstractBipolar disorder (BD) is a multifactorial chronic psychiatric disease highly defined by genetic, clinical, environmental and social risk factors. The present systematic review and meta-analysis aimed to examine the relationship between inflammatory and neurotrophic factors and clinical, social and environmental factors involved in the development and the characterization of BD. Web of Science, PubMed, PsycINFO, Scopus and Science Direct were searched by two independent reviewers. The systematic review was registered in PROSPERO (CRD42020180626). A total of 51 studies with 4547 patients with a diagnosis of BD were selected for systematic review. Among them, 18 articles were included for meta-analysis. The study found some evidence of associations between BDNF and/or inflammatory factors and different stressors and functional and cognitive impairment, but limitations prevented firm conclusions. The main finding of the meta-analysis was a negative correlation between circulating levels of BDNF and depression severity score (standardized mean difference = -0.22, Confidence Interval 95% = -0.38, -0.05, p = 0.01). Evidence indicates that BDNF has a role in the depressive component of BD. However, the poor consistency found for other inflammatory mediators clearly indicates that highly controlled studies are needed to identity precise biomarkers of this disorder.
dc.description.sponsorshipThis research was funded by Atención Primaria, Cronicidad y Promoción de la Salud: Red de Investigación en Atención Primaria de Adicciones (RIAPAd), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovación and European Regional Development Funds-European Union (ERDF-EU), grant number RD21/0009/0003; ISCIII, ERDF-EU, grant number PI19/01577; Ministerio de Sanidad, Delegación de Gobierno para el Plan Nacional sobre Drogas, grant numbers PND2019/040; and Consejería de Salud y Familia, Junta de Andalucía, grant numbers RIC-0111-2019. AV-N (CM19/00025) and CG-S-L (CM19/00240) hold “Rio Hortega” research contracts from the National System of Health, ISCIII, ERDF-EU. FM-C and JG-Ph have received funding from the Andalusia Government in the grants for human resources reinforcement in research activity (Acción A de intensificación 2019 and Acción B de refuerzos de larga duración 2014).
dc.description.versionSi
dc.identifier.citationVega-Núñez A, Gómez-Sánchez-Lafuente C, Mayoral-Cleries F, Bordallo A, Rodríguez de Fonseca F, Suárez J, et al. Clinical Value of Inflammatory and Neurotrophic Biomarkers in Bipolar Disorder: A Systematic Review and Meta-Analysis. Biomedicines. 2022 Jun 9;10(6):1368
dc.identifier.doi10.3390/biomedicines10061368
dc.identifier.issn2227-9059
dc.identifier.pmcPMC9220136
dc.identifier.pmid35740389
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220136/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2227-9059/10/6/1368/pdf?version=1655199639
dc.identifier.urihttp://hdl.handle.net/10668/20834
dc.issue.number6
dc.journal.titleBiomedicines
dc.journal.titleabbreviationBiomedicines
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number31
dc.provenanceRealizada la curación de contenido 18/03/2025
dc.publisherMDPI
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.projectIDRD21/0009/0003
dc.relation.projectIDIPI19/01577
dc.relation.projectIDPND2019/040
dc.relation.projectIDRIC-0111-2019
dc.relation.publisherversionhttps://www.mdpi.com/resolver?pii=biomedicines10061368
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectBDNF
dc.subjectBiomarker
dc.subjectBipolar disorder
dc.subjectClinical factors
dc.subjectCytokines
dc.subjectDepression
dc.subjectMania
dc.subjectMeta-analysis
dc.subjectNeurotrophins
dc.subjectSystematic review
dc.subject.decsFactor Neurotrófico Derivado del Encéfalo
dc.subject.decsRevisión Sistemática
dc.subject.decsFactores de Crecimiento Nervioso
dc.subject.decsTrastorno Bipolar
dc.subject.decsDisfunción Cognitiva
dc.titleClinical Value of Inflammatory and Neurotrophic Biomarkers in Bipolar Disorder: A Systematic Review and Meta-Analysis.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number10
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC9220136.pdf
Size:
2.67 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Vega-Nuñez_ClinicalValue_MaterialSuplementario.zip
Size:
997.86 KB
Format: